- Utilised for prophylaxis and treatment of venous thrombosis and it’s extension, prevention pf post-operative deep vein thrombosis, pulmonary embolism and prevention of clotting in arterial and cardiac surgery.
- Heparin is prescribed to prevent embolisms in patients with unstable angina or non-Q wave myocardial infarctions.
- Antithrombin III inactivates thrombin and factor Xa.
- Administered heparin binds reversibly to antithrombin III and leads immediately to inactivation of factors IIa and Xa.
- Acts mainly by accelerating the rate of the neutralisation of certain activated coagulation factors by antithrombin, but other mechanisms may be involved.
- The antithrombic effect of heparin is well correlated to the inhibition of fator Xa.
- Prevents progression of existing clots by inhibiting further clotting.
- Increased bruising
- Increased bleeding time
- Increased liver enzyme readings
- Severe affects could include internal bleeding
Some interaction include but are not limited to:
- Pain relief medication including aspirin as they have anticoagulation effects
- A select few medications used for heart and circulation problems including GTN and digitalis
- Anti-clotting medications such as Warfarin, Dectran and alteplase
- The median lethal dose is 5000mg/kg. It induces Heparin induced thrombocytopenia (HIT). HIT is caused by an immune response that makes platelets from clots within the vessels using coagulation factors. It can also cause arterial thrombosis, gangrene, stroke, myocardial infarction and disseminated intravascular coagulation.
- Symptoms of an overdose include excessive prolongation of aPTT or bleeding.
Pharmacokinetics
- Preferred method of administration is IV however can be administered subcutaneously. IV absorption and onset is immediate peak concentration is immediate. Subcutaneous action onset is between 20-60 minutes.
- Heparin binds to clotting factors antithrombin and fibrinogens. Components such as lipoproteins, proteases and globulins are also sites of heparin binding. All transported through the body though the venous system.
- Liver and the reticulo-endothelial system are the sites of biotransoformation.
Pharmacodynamics
- Typical half-life is 90 minutes.
- Plasma half-life of heparin increases from:
- 60 minutes with a 40unit/kg dose
- 150 minutes with a 100 unit/kg dose
- Action is immediate following IV administration and is effective for 3-6 hours
Clinical Resources Website
St John Ambulance Western Australia Ltd (ABN 55 028 468 715) (St John WA) operates ambulance and other pre-hospital clinical services. St John WA’s Clinical Resources, including its Clinical Practice Guidelines (Clinical Resources), are intended for use by credentialed St John WA staff and volunteers when providing clinical care to patients for or on behalf of St John WA, within the St John WA Clinical Governance Framework, and only to the extent of the clinician’s authority to practice.
Other users – Terms of Use
The content of the St John WA Clinical Resources is provided for information purposes only and is not intended to serve as health, medical or treatment advice. Any user of this website agrees to be bound by these Terms of Use in their use of the Clinical Resources.
St John WA does not represent or warrant (whether express, implied, statutory, or otherwise) that the content of the Clinical Resources is accurate, reliable, up-to-date, complete or that the information contained is suitable for your needs or for any particular purpose. You are responsible for assessing whether the information is accurate, reliable, up-to-date, authentic, relevant, or complete and where appropriate, seek independent professional advice.
St John WA expressly prohibits use of these Clinical Resources to guide clinical care of patients by organisations external to St John WA, except where these organisations have been directly engaged by St John WA to provide services. Any use of the Clinical Resources, with St John WA approval, must attribute St John WA as the creator of the Clinical Resources and include the copyright notice and (where reasonably practicable) provide a URL/hyperlink to the St John WA Clinical Resources website.
No permission or licence is granted to reproduce, make commercial use of, adapt, modify or create derivative works from these Clinical Resources. For permissions beyond the scope of these Terms of Use, including a commercial licence, please contact medservices@stjohnambulance.com.au
Where links are provided to resources on external websites, St John WA:
- Gives no assurances about the quality, accuracy or relevance of material on any linked site;
- Accepts no legal responsibility regarding the accuracy and reliability of external material; and
- Does not endorse any material, associated organisation, product or service on other sites.
Your use of any external website is governed by the terms of that website, including any authorisation, requirement or licence for use of the material on that website.
To the maximum extent permitted by law, St John WA excludes liability (including liability in negligence) for any direct, special, indirect, incidental, consequential, punitive, exemplary or other loss, cost, damage or expense arising out of, or in connection with, use or reliance on the Clinical Resources (including without limitation any interference with or damage to a user’s computer, device, software or data occurring in connection with such use).
Cookies
Please read this cookie policy carefully before using Clinical Resources from St John WA.
The cookies used on this site are small and completely anonymous pieces of information and are stored on your computer or mobile device. The data that the cookies contain identify your user preferences (such as your preferred text size, scope / skill level preference and Colour Assist mode, among other user settings) so that they can be recalled the next time that you visit a page within Clinical Resources. These cookies are necessary to offer you the best and most efficient possible experience when accessing and navigating through our website and using its features. These cookies do not collect or send analytical information back to St John WA.
Clinical Resources does integrate with Google Analytics and any cookies associated with this service enable us (and third-party services) to collect aggregated data for statistical purposes on how our visitors use this website. These cookies do not contain personal information such as names and email addresses and are used to help us improve your user experience of the website.
If you want to restrict or block the cookies that are set by our website, you can do so through your browser setting. Alternatively, you can visit www.internetcookies.com, which contains comprehensive information on how to do this on a wide variety of browsers and devices. You will find general information about cookies and details on how to delete cookies from your device. If you have any questions about this policy or our use of cookies, please contact us.